Association of Body Mass Index with Blood Pressure in Middle Aged Males
Association of Body Mass Index with Blood Pressure in Middle Aged Males
DOI:
https://doi.org/10.70284/njirm.v6i1.852Keywords:
Body Mass Index, Blood PressureAbstract
Background: Obesity is a condition in which excess body fat accumulates to such an extent that health may be adversely affected1. World Health Organization (WHO) has described rising rates of obesity in the developed world as an epidemic but even in a developing country like India incidence of obesity is rising2.Obesity is a major risk factor for chronic diseases like hypertension, type 2 diabetes mellitus, ischemic heart diseases, colonic cancer, osteoarthritis and stroke. Objectives: The present study was planned to find association (if any) of obesity status with blood pressure in middle aged males. Materials and Methods: 125 middle aged male subjects were recruited for the study after applying exclusion criteria. According to their body mass index( BMI), they were divided in control, overweight & obese groups & their blood pressures were measured. Statistical analysis was done using t test & coefficient of correlation. Results: Higher values of systolic and diastolic blood pressure were found in overweight & obese group as compared to control group which were statistically significant. Statistically significant positive correlation between BMI and systolic as well as diastolic blood pressure was found. Interpretation and Conclusions: Higher values of systolic & diastolic blood pressures in both overweight & obese groups reiterates the role of higher BMI as a cardiovascular risk factor. It is necessary to impart health education to general public regarding health risks associated with higher BMI. [Phadke A NJIRM 2015; 6(1):40-44]
References
2. Parizkova Jana, Chin Ming-Kai, Chia Micheal, Yang Jingzhen. An international perspective on obesity, health and physical activity: Current trends and challenges in China and Asia, Journal of exercise science fitness. 2007; 5 (1): 7-23.
3. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva, World Health Organization, 2009.
4. Treatment of Hypertension in Adults with Diabetes American Diabetes Association Diabetes Care, Vol.25(1), January 2002; 71-73.
5. Park K. Assessment of body mass index. Park’s Textbook of preventive and social medicine. 21st Edition Jabalpur, Banarsidas Bhanot, 2011; 368-369.
6. V G Ranade, Measurement of blood pressure, Textbook of Practical Physiology 4th edition, Pune Vidyarthigriha Prakashan 1986; 426-435.
7. N. K. Mungreiphy, SatwantiKapoor, RashmiSinha. Association between BMI, Blood Pressure, and Age: Study among Tangkhul Naga Tribal males of Northeast India. Journal of Anthropology, Volume 2011:1-6.
8. Mohammed Taha Al-Hariri Association of blood pressure and random blood glucose with weight status of normal male population in Saudi Arabia. Pakistan Journal of Physiology 2012; 8(1): 35-37.
9. Sc Ho, YM Chen, JLF Woo, SSF Leung, TH Lam and ED Janus. Association between simple anthropometric indices and cardiovascular risk factors. International Journal of Obesity. 2001; 25: 1689-1697.
10. Kissebah AH, Krakower GR Regional adiposity and morbidity. Physiology Review 1994, 74:761–811.
11. Festa A, D’Agostino R Jr, Howard G, Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS).2000. Circulation102:42–47.
12. Crandall DL, Ferraro GD, Cervoni P. Effect of experimental obesity and subsequent weight reduction upon circulating atrial natriureticpeptide. Proceedings of the Society for Experimental Biology and Medicine. 1989 191:352–356.
13. E. A. Francischetti, V. A. Genelhu. Obesity- hypertension: an ongoing pandemic. International Journal of Clinical Practice. February 2007; 61 :( 2) 269-280.
14. Umemura S, Nyui N, Tamura K. Plasma angiotensinogen concentrations in obese patients. Hypertension 1997; 10: 629-633.
15. Rahmouni K, Correia MLG, Haynes WG, Mark Al. Obesity-associated hypertension: new insight into mechanisms. Hypertension 2005; 45: 9-14.
16. Hall JE, Brands MW, Henegar JR, Mechanisms of hypertension and kidney disease in obesity. Annual of New York Academy Science 1999; 892: 91-107.
17. Robles RG, Villa E, Santirso R. Effects of captopril on sympathetic activity, lipid and carbohydrate metabolism in a model of obesity-induced hypertension in dogs. Hypertension 1993; 6: 1009-1015.
18. Reisin E, Weir MR, and Falkner B. Lisinopril versus hydrochlorothiazide in obese hypertensive Patients: a multicenter placebo controlled trial. Treatment in obese patients with hypertension (TROPHY) Study group. Hypertension.1997; 30: 140-5.
19. Sharma AM. Is there a rational for angiotensin blockade in the management of obesity hypertension? Hypertension 2004; 44: 12-9.
20. Grassi G, Servalle G, Cattaneo BM. Sympathetic activity in obese normotensive subjects. Hypertension 1995; 25: 260-3.
21. Rumantir Ms, Vaz M, Jennings GL. Neural mechanisms in human obesity related hypertension. Hypertension 1999; 17: 1125-1133.
